Choroidal dendritic cells require activation to present antigen and resident choroidal macrophages potentiate this response.
OBJECTIVE
The uveal compartment of the eye contains extensive networks of resident macrophages and dendritic cells. These cells are now recognised to have a role in many ocular pathologies. The aim of this study was to isolate, characterise, and compare the function of ciliary body/choroid dendritic cells and macrophages from the normal eye.


METHODS
Explants of rat and human ciliary body/choroid were cultured in vitro for various periods of time and cells harvested either from the supernatant fluid or from enzyme digested and washed explants. The cells were then phenotyped by microscopy and flow cytometry, examined by video time lapse photomicroscopy, and analysed functionally in a series of immunoassays.


RESULTS
Two main types of dendritic cell were identified: large veil-like MHC class II(mid) motile but relatively non-translocatory cells and small MHC class II(hi) motile and rapidly translocating cells. Tissue macrophages mainly remained associated with the explants in culture but gradually lost their resident tissue marker (ED2) and detached from the explants as clusters of low density, large, CR3 (ED7)(+) cells, some of which underwent apoptosis. Video time lapse studies showed dendritic cells constantly interacting with large single cells and cell clusters by traversing the interstices of the cell clusters. In functional studies, freshly isolated dendritic cells were poor presenters of antigen and required activation by short term culture for acquisition of antigen presenting function. In contrast, dendritic cell depleted choroidal cell preparations containing macrophages and other cells failed to present antigen even after short term culture but augmented the antigen presenting function of dendritic cells when tested in co-culture.


CONCLUSIONS
At least two types of dendritic cells are present in the normal ciliary body/choroid layer of the eye. It is likely that these cells have different functions based on their motility and potential to migrate to secondary lymphoid tissue either during normal physiological homeostatic processes or during an inflammatory response. The behaviour of resident tissue myeloid cells may decide the outcome of the organism's response to stress, foreign antigen, and ageing processes such as age related macular degeneration.
Forrester
J V
JV
Department of Ophthalmology, University of Aberdeen, Foresterhill, Aberdeen AB9 2ZD, UK. j.forrester@abdn.ac.uk
Lumsden
L
L
Duncan
L
L
Dick
A D
AD
D000818:Animals; D017951:Antigen Presentation; D017209:Apoptosis; D018929:Cell Culture Techniques; D002829:Choroid / Q000276:immunology*; D002924:Ciliary Body / Q000276:immunology*; D003713:Dendritic Cells / Q000276:immunology*; D005434:Flow Cytometry; D006801:Humans; D016130:Immunophenotyping; D007959:Lymphocyte Culture Test, Mixed; D008264:Macrophages / Q000276:immunology*; D008858:Microscopy, Phase-Contrast; D018715:Microscopy, Video; D051381:Rats; D011917:Rats, Inbred Lew
J Immunol. 1996 Sep 15;157(6):2262-71
8805623
Br J Ophthalmol. 1999 May;83(5):598-604
10216062
Annu Rev Immunol. 1991;9:271-96
1910679
Br J Ophthalmol. 1995 Sep;79(9):834-40
7488603
Curr Opin Immunol. 1997 Feb;9(1):10-6
9039784
Br J Ophthalmol. 2001 Jun;85(6):739-44
11371497
Immunology. 1990 Jan;69(1):127-33
2138123
Exp Eye Res. 1994 Sep;59(3):297-304
7821374
Curr Eye Res. 1988 Dec;7(12):1231-41
3229134
Clin Exp Immunol. 1999 Feb;115(2):288-93
9933455
J Exp Med. 1993 Feb 1;177(2):397-407
8426110
Immunology. 1996 Feb;87(2):250-8
8698387
Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):351-8
11773639
Histochem J. 1996 Feb;28(2):83-97
8737290
Annu Rev Immunol. 2003;21:685-711
12615891
Eur Respir J. 1994 Dec;7(12):2124-30
7713193
J Exp Med. 1993 Jun 1;177(6):1773-7
8496690
Nat Med. 2003 Nov;9(11):1390-7
14566334
Invest Ophthalmol Vis Sci. 1994 Jan;35(1):64-77
8300365
Invest Ophthalmol Vis Sci. 1994 Jul;35(8):3234-50
8045716
J Immunol. 1997 Apr 1;158(7):3125-9
9120265
Invest Ophthalmol Vis Sci. 2003 Jul;44(7):3083-93
12824255
Invest Ophthalmol Vis Sci. 2003 May;44(5):2004-9
12714636
Immunology. 2000 Nov;101(3):426-33
11106948
Biotechniques. 1991 Oct;11(4):520-5
1793587
Ocul Immunol Inflamm. 2000 Sep;8(3):177-87
11120579
Invest Ophthalmol Vis Sci. 1996 Sep;37(10):1940-50
8814133
J Exp Med. 1996 Aug 1;184(2):741-6
8760828
Immunology. 1990 Nov;71(3):390-6
1980120
J Leukoc Biol. 1999 Aug;66(2):205-8
10449155
Br J Ophthalmol. 1997 May;81(5):396-401
9227206
J Neuroimmunol. 1996 Aug;68(1-2):67-76
8784262
J Immunol. 1997 Nov 15;159(10):5132-42
9366443
Invest Ophthalmol Vis Sci. 2002 Jul;43(7):2264-71
12091426
Immunity. 2003 Jul;19(1):47-57
12871638
Methods Enzymol. 1988;162:17-38
3067050
Exp Eye Res. 1987 Nov;45(5):731-45
3428396
Nat Med. 2003 Nov;9(11):1350-1
14595424
Invest Ophthalmol Vis Sci. 2003 Feb;44(2):581-9
12556386
J Immunol. 2004 Jun 1;172(11):6701-8
15153486
J Exp Med. 1998 Mar 2;187(5):733-41
9480983